MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymthe.2026.09.037

Медицинская библиотека · Molecular therapy : the journal of the American Society of Gene Therapy · 2026

Cryo-thermal therapy reprograms myeloid cells into CCL5+ mature phenotype to increase T-cell infiltration and potentiates anti-PD-1 therapy.

Hao Yuankai, Zhang Zelu, Wang Shicheng, Wang Ke, Liu Xiaohui, Liu Ping

СтатьяПеревод пока не подготовлен

Аннотация

Although immune checkpoint blockade (ICB) represented by anti-PD-1 therapy has demonstrated significant clinical benefits, its efficacy remains limited by the immunosuppressive tumor microenvironment (TME). Our study revealed that the combination of Cryo-thermal therapy (CTT) and anti-PD-1 therapy suppresses the distal tumor growth compared to either cryoablation or radiofrequency ablation combined with anti-PD-1 therapy. Mechanistically, CTT specifically induces TNF-α production in mature myeloid cells, triggering autocrine CCL5 secretion that recruits peripheral IFN-γ+ T cells induced by CTT in distal tumors, creating a cytokine loop in which IFN-γ derived from T cells and TNF-α derived from myeloid cells collectively promote CCL5 secretion in myeloid cells to increase effector T-cell recruitment in distal tumors. After CTT, anti-PD-1 treatment amplifies this cascade by enhancing TNF-α production in T cells. The parallel activation of STAT1 by IFN-γ and NF-κB by TNF-α in myeloid cells converges to drive IRF7-dependent CCL5 upregulation to create a local immune enhancing environment via CCL5-mediated recruitment of T cells. Our study demonstrates that CTT establishes an immunologically favorable TME by reprogramming immunosuppressive myeloid cells into mature myeloid cells with high CCL5 production, thereby facilitating effector T-cell recruitment, providing an efficient therapeutic strategy to promote the response to anti-PD-1 therapy.

Для цитирования: Hao Yuankai, Zhang Zelu, Wang Shicheng, Wang Ke, Liu Xiaohui, Liu Ping. Cryo-thermal therapy reprograms myeloid cells into CCL5+ mature phenotype to increase T-cell infiltration and potentiates anti-PD-1 therapy.. Molecular therapy : the journal of the American Society of Gene Therapy. 2026. DOI: 10.1016/j.ymthe.2026.09.037.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.